Compounded tirzepatide is a custom interpretation of the medication, typically made at peculiarity pharmacies but not reviewed or sanctioned by the Food and Drug Administration. It is usable to patients who demand a customised dosing or expression that is not commercially uncommitted. Approved in 2010, Saxenda (liraglutide) was the foremost GLP-1 medicament sanctioned for angle
